Skip to main content
. 2021 Apr 23;13(9):2051. doi: 10.3390/cancers13092051

Table 2.

Genes related to the “drug resistance” process modulated in the multidrug-resistant 82.3 cells compared to the sensitive MT-CHC01.

Up-Regulated Genes Average Fold Change SD Down-Regulated Genes Average Fold Change SD
AHR 152.60 4.39 ABCC1 0.11 0.04
APC 8.80 1.82 ABCC2 0.04 0.01
ARNT 3.06 0.46 ABCC3 0.33 0.08
BCL2 2.22 0.49 ABCC5 0.25 0.08
BRCA2 11.43 1.41 BAX 0.46 0.07
CCND1 1.67 0.44 BCL2L1 0.09 0.03
CDKN1A 29.58 0.44 CCNE1 0.26 0.03
CYP2E1 6.37 1.99 CDK2 0.41 0.07
EGFR 5.15 1.60 CDK4 0.28 0.14
EPHX1 1.69 0.51 CDKN1B 0.27 0.15
HIF1A 7.07 0.87 CLPTM1L 0.07 0.02
MET 3.16 0.40 CYP3A5 0.11 0.03
MSH2 5.66 1.25 ELK1 0.01 0.01
MYC 1.74 0.19 ERBB2 0.16 0.08
NAT2 10.82 0.17 GSK3A 0.20 0.06
PPARA 2.19 0.31 GSTP1 0.40 0.13
PPARG 9.29 1.41 MVP 0.15 0.07
RB1 5.11 0.74 NFKB2 0.22 0.00
SOD1 1.69 0.17 NFKBIB 0.27 0.07
TOP2A 3.91 0.54 RARA 0.39 0.07
TOP2B 16.13 1.66 RARG 0.18 0.05
TPMT 6.25 0.01 RELB 0.36 0.08
UGCG 6.69 0.43 RXRA 0.18 0.04
- - - RXRB 0.49 0.14
- - - SULT1E1 0.34 0.04
- - - TP53 0.07 0.02